These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2521841)

  • 1. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
    Sasiain MD; de la Barrera S; Valdez R; Balina LM
    Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppression in leprosy].
    Sasiain MC; de la Barrera S
    Medicina (B Aires); 1989; 49(3):213-5. PubMed ID: 2535042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
    Sasiain MC; Ruibal Ares B; Baliña LM; Valdez R; Bachmann AE
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell regulation in lepromatous leprosy.
    Bobosha K; Wilson L; van Meijgaarden KE; Bekele Y; Zewdie M; van der Ploeg-van Schip JJ; Abebe M; Hussein J; Khadge S; Neupane KD; Hagge DA; Jordanova ES; Aseffa A; Ottenhoff TH; Geluk A
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2773. PubMed ID: 24722473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function.
    Negera E; Bobosha K; Aseffa A; Dockrell HM; Lockwood DNJ; Walker SL
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010641. PubMed ID: 35867720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of chemiluminescence, procoagulant activity and antigen presentation by monocytes from lepromatous leprosy patients with or without reactional episodes.
    Santos DO; Suffys PN; Moreira AL; Bonifacio K; Salgado JL; Esquenazi D; Bertho AL; Sarno EN
    Lepr Rev; 1994 Jun; 65(2):88-99. PubMed ID: 7968194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
    Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
    Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
    Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy.
    Saini C; Prasad HK; Rani R; Murtaza A; Misra N; Shanker Narayan NP; Nath I
    Clin Vaccine Immunol; 2013 May; 20(5):673-82. PubMed ID: 23446220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.
    Sadhu S; Khaitan BK; Joshi B; Sengupta U; Nautiyal AK; Mitra DK
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004338. PubMed ID: 26751584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM; Mineo JR; Foss NT
    Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged dapsone chemotherapy.
    Gill HK; Ridley DS; Ganesan J; Mustafa AS; Rees RJ; Godal T
    Lepr Rev; 1990 Mar; 61(1):25-31. PubMed ID: 2181222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of immunosuppression in leprosy: presence of suppressor factor(s) from macrophages of lepromatous patients.
    Salgame PR; Mahadevan PR; Antia NH
    Infect Immun; 1983 Jun; 40(3):1119-26. PubMed ID: 6221997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.